M&A activity in the pharmaceutical industry in France increased in 2023
In value terms, M&A activity in France decreased by 88% in Q2 2023 compared with the previous quarter’s total of $2.6bn and fell by 6% as compared to Q2 2022. Related deal volume increased by 22% in Q2 2023 versus the previous quarter and was 175% higher than in Q2 2022.
The top-ranked financial advisors supporting these M&A deals in France in Q2 2023 were BNP Paribas; Clearwater International; KPMG International Coop with 2, 2, 2 deals respectively.
The top-ranked legal advisorss supporting these M&A deals in France Q2 2023 were CMS Legal Services EEIG; Kirkland & Ellis; CLARIS Avocats with 2, 2, 1 deals respectively.
For further understanding of GlobalData’s Pharma Industry Mergers and Acquisitions Deals by Top Themes, buy the report here.
Source link
#activity #pharmaceutical #industry #France #increased